Analyst Downgrades – NASDAQ:HALO – Halozyme (NASDAQ:HALO) Stock Gets Downgraded By Barclays from Equal Weight ➝ Underweight to

ME Staff

7 years ago

Analyst Ratings For NASDAQ:HALO – Halozyme (NASDAQ:HALO)

Today, NASDAQ:HALO – Halozyme (NASDAQ:HALO) stock was downgraded by Barclays from Equal Weight ➝ Underweight to with a price target of $19.00.

Some recent analyst ratings include

5/11/2018-Barclays was Downgraded by analysts at Barclays from a “Equal Weight ➝ Underweight” rating to a “” rating. They now have a $19.00 price target on the stock.
2/22/2018-BMO Capital Markets Reiterated Rating of Market Perform ➝ Market Perform.
2/21/2018-JPMorgan Chase Reiterated Rating of Overweight ➝ Overweight.
1/24/2018-Goldman Sachs initiated coverage with a Neutral ➝ Neutral rating.

Recent Insider Trading Activity For NASDAQ:HALO – Halozyme (NASDAQ:HALO)
NASDAQ:HALO – Halozyme (NASDAQ:HALO) has insider ownership of 16.80% and institutional ownership of 86.13%.

On 8/20/2015 Laurie Stelzer, CFO, bought 10,000 with an average share price of $17.24 per share and the total transaction amounting to $172,400.00.
On 6/18/2015 Kenneth J Kelley, Director, sold 20,000 with an average share price of $21.00 per share and the total transaction amounting to $420,000.00.
On 9/16/2014 David A Ramsay, CFO, bought 25,000 with an average share price of $8.90 per share and the total transaction amounting to $222,500.00.
On 9/16/2014 Helen Torley, CEO, bought 50,000 with an average share price of $8.92 per share and the total transaction amounting to $446,000.00.
On 8/19/2014 John Stuart Patton, Director, sold 75,000 with an average share price of $9.96 per share and the total transaction amounting to $747,000.00.
On 5/15/2014 Robert Engler, Director, sold 126,700 with an average share price of $7.56 per share and the total transaction amounting to $957,852.00.
On 9/16/2013 John Stuart Patton, Director, sold 75,000 with an average share price of $9.13 per share and the total transaction amounting to $684,750.00.

Recent Trading Activity for NASDAQ:HALO – Halozyme (NASDAQ:HALO)
Shares of NASDAQ:HALO – Halozyme closed the previous trading session at with 2322338 shares trading hands.